NCT02840149View on ClinicalTrials.gov

SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

December 13, 2023

Study Completion Date

December 13, 2023

Conditions
Neuroendocrine Tumors
Interventions
DRUG

68Ga-DOTATATE PET/CT

68Ga-DOTATATE PET/CT scan

Trial Locations (1)

H4R3E8

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Jewish General Hospital

OTHER

NCT02840149 - SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors | Biotech Hunter | Biotech Hunter